Carvedilol

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Otilonium bromide for treating irritable bowel syndrome

EU DMF

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Tafamidis for Trnsthyretin amyloidosis

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Aclidinium. Indication: COPD treatment

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Aprepitant. Indication: Emesis

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Arformoterol tartrate. Indication for COPD 

US and CN DMF available

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Asenapine. Indications: Schizophrenia and acute mania

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Clevidipine. Indication: Hypertension

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Desloratadine. Indication: Allergy

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Eletriptan HBr. Indications: Migraine

JP DMF available

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Enalapril maleate. Indication: Hypertension

CEP and KR DMF available

Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Formoterol. Indications Asthma and COPD. CEP and US-JP-KR-CN DMF available

Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Glycopyrrolate Bromide.  Indication: COPD. CEP and US and CN DMF available

Complete overview of Inke’s API product portfolio and development pipeline, covering Inhalation, CNS, Ophthalmic HPAPIs and Specialty APIs. The document includes product indications, micronisation availability, regulatory status (CEPs and DMFs), and development stage information for pipeline products.